Latest Elias Zerhouni Stories
- Former Director of the NIH Vaccine Research Center to Spearhead Sanofi Efforts, and Contribution to Global Fight against Ebola - PARIS, Nov.
ROCHESTER, N.Y. and LONDON, July 14, 2014 /PRNewswire/ -- VirtualScopics, Inc.
A new study by Rice University's Baker Institute for Public Policy illustrates a disconnect between government funding of biomedical research by young investigators and a novel standard by which to judge it: the Nobel Prize.
LYON, France, December 20, 2010 /PRNewswire/ -- For its 7th meeting, BioVision (27-29 March at Lyon in France) will feature a new platform << business in science >> centred on the theme: "The end of the traditional life science industry model: what's next?" 28 international experts will be considering the future of the traditional model of the life sciences industry.
WASHINGTON, Dec. 10 /PRNewswire-FirstCall/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has appointed Elias A. Zerhouni, M.D. to Danaher's Board of Directors. Dr. Zerhouni's initial term expires at Danaher's 2011 annual meeting of shareholders. Dr.
In remarks at the Forum for the Future in Marrakech yesterday, Secretary Clinton announced new initiatives to bolster science and technology collaboration with Muslim communities around the world.
ROCHESTER, Minn., May 29 /PRNewswire-USNewswire/ -- Former director of the National Institutes of Health (NIH), Elias A. Zerhouni, M.D., has joined the Mayo Clinic Board of Trustees. Dr.
- The act of sweetening by admixture of some saccharine substance.